In the BioHarmony Drug Report Database

"Preview" Icon

Quinidine

Quinidex (quinidine) is a small molecule pharmaceutical. Quinidine was first approved as Quinidex on 1982-01-01. It is used to treat atrial fibrillation, atrial flutter, and cardiac arrhythmias in the USA. It is known to target potassium channel subfamily U member 1, potassium voltage-gated channel subfamily H member 1, potassium voltage-gated channel subfamily H member 5, potassium voltage-gated channel subfamily A member 5, equilibrative nucleoside transporter 4, potassium voltage-gated channel subfamily A member 7, potassium channel subfamily K member 5, potassium channel subfamily T member 1, potassium channel subfamily T member 2, potassium channel subfamily K member 18, potassium channel subfamily K member 6, potassium channel subfamily K member 16, potassium channel subfamily K member 10, potassium voltage-gated channel subfamily A member 4, sodium channel protein type 5 subunit alpha, potassium voltage-gated channel subfamily D member 2, and cytochrome P450 2D6.

 

Trade Name

 

Quinidex
 

Common Name

 

quinidine
 

ChEMBL ID

 

CHEMBL1294
 

Indication

 

atrial fibrillation, atrial flutter, cardiac arrhythmias
 

Drug Class

 

Image (chem structure or protein)

Quinidine structure rendering